Synergistic Cytotoxicity of Recombinant Human TNF and Various Anti-Cancer Drugs
Authors:
- Yoshiro NiitsuYNYoshiro Niitsu
- Naofumi YamauchiNYNaofumi Yamauchi
- Yoshiki OhtsukaYOYoshiki Ohtsuka
- Hisao SoneHSHisao Sone
- Hiroshi NedaHNHiroshi Neda
- Masahiro MaedaMMMasahiro Maeda
- Ichiro UrushizakiIUIchiro Urushizaki
- 1 January 1988
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 10 (1) , 117-127
Abstract
A synergistic increase in the cytotoxic effects of recombinant human tumor necrosis factor (rH-TNF) and anti-cancer drugs was demonstrated in vitro. The cytotocicity of rH-TNF against L-M cells in combination with Mitomycin C (MMC), Adriamycin (ADM), Cytosine arabinoside (Ara- C), Actinomycin D (ACD), Daunomycin (DM), Cisplatin (CDDP), Vincristin (VCR), and 5-Flurouracil (5FU), based on the concentration necessary for 50% inhibition of cell growth (IC50), was 4 to 347 times as high as that of rH-TNF alone. The results suggest that combination therapy including rH-TNF and anti-cancer drugs may be of value in the treatment of malignancy in human patients.Keywords
This publication has 4 references indexed in Scilit:
- PROPOSAL OF STANDARDIZED METHODS AND REFERENCE FOR ASSAYING RECOMBINANT HUMAN TUMOR NECROSIS FACTORJapanese Journal of Medical Science and Biology, 1986
- Rabbit tumor necrosis factor: mechanism of actionInfection and Immunity, 1981
- Stimulation of RNA Synthesis in L-929 Cells by Rabbit Tumor Necrosis FactorExperimental Biology and Medicine, 1979
- Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1979